Related Experiment Video
Updated: Jan 4, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer
Stefania Morganti1,2, Paolo Tarantino1,2, Emanuela Ferraro1,2
1Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Abstract:
Following the completion of the Human Genome Project in 2003, research in oncology has progressively focused on the sequencing of cancer genomes, with the aim of better understanding the genetic basis of oncogenesis and identifying actionable alterations. The development of next-generation-sequencing (NGS) techniques, commercially available since 2006, allowed for a cost- and time-effective sequencing of tumor DNA, leading to a "genomic era" of cancer research and treatment. NGS provided a significant step forward in Personalized Medicine (PM) by enabling the detection of somatic driver mutations, resistance mechanisms, quantification of mutational burden, germline mutations which settled the foundation of a new approach in cancer care. In this chapter we discuss the history, available techniques and applications of NGS in oncology, with a particular referral to the PM approach and the emerging role of the research field of pharmacogenomics.
Insights
Next-generation sequencing (NGS) transformed cancer research by enabling cost-effective tumor DNA analysis. This genomic era approach underpins personalized medicine and pharmacogenomics in oncology.
Area of Science:
- Oncology
- Genomics
- Personalized Medicine
Background:
- The Human Genome Project spurred focus on cancer genome sequencing.
- Next-generation sequencing (NGS) emerged in 2006, revolutionizing tumor DNA analysis.
- NGS facilitated a shift towards a genomic era in cancer research and treatment.
Purpose of the Study:
- To review the history, techniques, and applications of NGS in oncology.
- To highlight the role of NGS in advancing Personalized Medicine (PM).
- To discuss the emerging field of pharmacogenomics in cancer care.
Main Methods:
- Review of historical developments in cancer genome sequencing.
- Discussion of available Next-Generation Sequencing (NGS) technologies.
- Analysis of NGS applications in identifying actionable cancer alterations.
Main Results:
- NGS enables cost- and time-effective sequencing of tumor DNA.
- NGS is crucial for detecting somatic mutations, resistance mechanisms, and mutational burden.
- NGS supports the identification of germline mutations for improved cancer care.
Conclusions:
- NGS has established the foundation for a new paradigm in cancer care.
- NGS is integral to the advancement of Personalized Medicine in oncology.
- Pharmacogenomics is an increasingly important research area within NGS-driven cancer treatment.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11:02Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genomics
Cancer
Sanger Sequencing
Targeted Cancer Therapies
There are several types of targeted therapies against...